82 FR 29624 - Qualification of Drivers; Exemption Applications; Epilepsy and Seizure Disorders

DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety Administration

Federal Register Volume 82, Issue 124 (June 29, 2017)

Page Range		29624-29626
FR Document		2017-13618

FMCSA announces receipt of applications from seven individuals for an exemption from the prohibition in the Federal Motor Carrier Safety Regulations (FMCSRs) against persons with a clinical diagnosis of epilepsy or any other condition that is likely to cause a loss of consciousness or any loss of ability to control a commercial motor vehicle (CMV) to drive in interstate commerce. If granted, the exemptions would enable these individuals who have had one or more seizures and are taking anti-seizure medication to operate CMVs in interstate commerce.

Federal Register, Volume 82 Issue 124 (Thursday, June 29, 2017)

[Federal Register Volume 82, Number 124 (Thursday, June 29, 2017)]
[Notices]
[Pages 29624-29626]
From the Federal Register Online [www.thefederalregister.org]
[FR Doc No: 2017-13618]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Motor Carrier Safety Administration

[Docket No. FMCSA-2017-0178]

Qualification of Drivers; Exemption Applications; Epilepsy and
Seizure Disorders

AGENCY: Federal Motor Carrier Safety Administration (FMCSA), DOT.

ACTION: Notice of applications for exemption; request for comments.

-----------------------------------------------------------------------

SUMMARY: FMCSA announces receipt of applications from seven individuals
for an exemption from the prohibition in the Federal Motor Carrier
Safety Regulations (FMCSRs) against persons with a clinical diagnosis
of epilepsy or any other condition that is likely to cause a loss of
consciousness or any loss of ability to control a commercial motor
vehicle (CMV) to drive in interstate commerce. If granted, the
exemptions would enable these individuals who have had one or more
seizures and are taking anti-seizure medication to operate CMVs in
interstate commerce.

DATES: Comments must be received on or before July 31, 2017.

ADDRESSES: You may submit comments bearing the Federal Docket
Management System (FDMS) Docket No. FMCSA-2017-0178 using any of the
following methods:
Federal eRulemaking Portal: Go to http://www.regulations.gov. Follow the online instructions for submitting
comments.
Mail: Docket Management Facility; U.S. Department of
Transportation, 1200 New Jersey Avenue SE., West Building Ground Floor,
Room W12-140, Washington, DC 20590-0001.
Hand Delivery: West Building Ground Floor, Room W12-140,
1200

[[Page 29625]]

New Jersey Avenue SE., Washington, DC, between 9 a.m. and 5 p.m., e.t.,
Monday through Friday, except Federal Holidays.
Fax: 1-202-493-2251.
Instructions: Each submission must include the Agency name and the
docket number(s) for this notice. Note that all comments received will
be posted without change to http://www.regulations.gov, including any
personal information provided. Please see the Privacy Act heading below
for further information.
Docket: For access to the docket to read background documents or
comments, go to http://www.regulations.gov at any time or Room W12-140
on the ground level of the West Building, 1200 New Jersey Avenue SE.,
Washington, DC, between 9 a.m. and 5 p.m., e.t., Monday through Friday,
except Federal holidays. The FDMS is available 24 hours each day, 365
days each year. If you want acknowledgment that we received your
comments, please include a self-addressed, stamped envelope or postcard
or print the acknowledgement page that appears after submitting
comments online.
Privacy Act: In accordance with 5 U.S.C. 553(c), DOT solicits
comments from the public to better inform its rulemaking process. DOT
posts these comments, without edit, including any personal information
the commenter provides, to http://www.regulations.gov as described in
the system records notice (DOT/ALL-14 FDMS), which can be reviewed at
http://www.dot.gov/privacy.

FOR FURTHER INFORMATION CONTACT: Ms. Christine A. Hydock, Chief,
Medical Programs Division, (202) 366-4001, fmcsamedical@dot.gov, FMCSA,
Department of Transportation, 1200 New Jersey Avenue SE., Room W64-224,
Washington, DC 20590-0001. Office hours are 8:30 a.m. to 5 p.m., e.t.,
Monday through Friday, except Federal holidays. If you have questions
regarding viewing or submitting material to the docket, contact Docket
Services, telephone (202) 366-9826.

SUPPLEMENTARY INFORMATION:

I. Background

Under 49 U.S.C. 31136(e) and 31315, FMCSA may grant an exemption
from the FMCSRs for a two-year period if it finds ``such exemption
would likely achieve a level of safety that is equivalent to or greater
than the level that would be achieved absent such exemption.'' The
statute also allows the Agency to renew exemptions at the end of the
two-year period.
The nine individuals listed in this notice have requested an
exemption from the epilepsy prohibition in 49 CFR 391.41(b)(8).
Accordingly, the Agency will evaluate the qualifications of each
applicant to determine whether granting the exemption will achieve the
required level of safety mandated by statute.
The physical qualification standard for drivers regarding epilepsy
found in 49 CFR 391.41(b)(8) states that a person is physically
qualified to drive a CMV if that person:

Has no established medical history or clinical diagnosis of
epilepsy or any other condition which is likely to cause the loss of
consciousness or any loss of ability to control a CMV.

In addition to the regulations, FMCSA has published advisory
criteria \1\ to assist Medical Examiners in determining whether drivers
with certain medical conditions are qualified to operate a CMV in
interstate commerce. [49 CFR part 391, APPENDIX A TO PART 391--MEDICAL
ADVISORY CRITERIA, section H. Epilepsy: Sec. 391.41(b)(8), paragraphs
3, 4, and 5.]
---------------------------------------------------------------------------

\1\ See http://www.ecfr.gov/cgi-bin/text-idx?SID=e47b48a9ea42dd67d999246e23d97970&mc=true&node=pt49.5.391&rgn=div5#ap49.5.391_171.a and https://www.thefederalregister.org/fdsys/pkg/CFR-2015-title49-vol5/pdf/CFR-2015-title49-vol5-part391-appA.pdf.
---------------------------------------------------------------------------

The advisory criteria state the following:
If an individual has had a sudden episode of a non-epileptic
seizure or loss of consciousness of unknown cause that did not require
anti-seizure medication, the decision whether that person's condition
is likely to cause the loss of consciousness or loss of ability to
control a CMV should be made on an individual basis by the Medical
Examiner in consultation with the treating physician. Prior to
considering certification, it is suggested there be a six-month waiting
period from the time of the episode. Following the waiting period, it
is suggested that the individual undergo a complete neurological
examination. If the results of the examination are negative and anti-
seizure medication is not required, the driver may be qualified.
In those individual cases where a driver had a seizure or an
episode of loss of consciousness that resulted from a known medical
condition (e.g., drug reaction, high temperature, acute infectious
disease, dehydration, or acute metabolic disturbance), certification
should be deferred until the driver has recovered fully from that
condition, has no existing residual complications, and is not taking
anti-seizure medication.
Drivers who have a history of epilepsy/seizures, off anti-seizure
medication and seizure-free for 10 years, may be qualified to operate a
CMV in interstate commerce. Interstate drivers who have had a single
unprovoked seizure may be qualified to drive a CMV in interstate
commerce if seizure-free and off anti-seizure medication for five years
or more.
As a result of Medical Examiners misinterpreting advisory criteria
as regulation, numerous drivers have been prohibited from operating a
CMV in interstate commerce based on the fact that they have had one or
more seizures and are taking anti-seizure medication, rather than an
individual analysis of their circumstances by a qualified Medical
Examiner based on the physical qualification standards and medical best
practices.
On January 15, 2013, in a Notice of Final Disposition entitled,
``Qualification of Drivers; Exemption Applications; Epilepsy and
Seizure Disorders,'' (78 FR 3069), FMCSA announced its decision to
grant requests from 22 individuals for exemptions from the regulatory
requirement that interstate CMV drivers have ``no established medical
history or clinical diagnosis of epilepsy or any other condition which
is likely to cause loss of consciousness or any loss of ability to
control a CMV.'' Since the January 15, 2013 notice, the Agency has
published additional notices granting requests from individuals for
exemptions from the regulatory requirement regarding epilepsy found in
49 CFR 391.41(b)(8).
To be considered for an exemption from the epilepsy prohibition in
49 CFR 391.41(b)(8), applicants must meet the criteria in the 2007
recommendations of the Agency's Medical Expert Panel (MEP) (78 FR
3069).

II. Qualifications of Applicants

Richard A. Bailey

Mr. Bailey is a 67 year-old class A CDL holder in Iowa. He has a
history of a seizure disorder and his last seizure was 2009. He takes
anti-seizure medication with the dosage and frequency remaining the
same since that time. His physician states that he is supportive of Mr.
Bailey receiving an exemption.

Roosevelt J. Chambers

Mr. Chambers is a 71 year-old driver in Washington. He has a
history of epilepsy and his last seizure was in 2007. He takes anti-
seizure medication with the dosage and frequency remaining the same
since 2006. His

[[Page 29626]]

physician states that he is supportive of Mr. Chambers receiving an
exemption.

Donnie D. Kuck

Mr. Kuck is a 61 year-old driver in Montana. He has a history of a
seizure disorder and his last seizure was in 1986. He takes anti-
seizure medication with the dosage and frequency remaining the same
since that time. His physician states that he is supportive of Mr. Kuck
receiving an exemption.

Mario A. Palomares

Mr. Palomares is a 46 year-old driver in Texas. He has a history of
a seizure disorder and his last seizure was in 1985. He takes anti-
seizure medication with the dosage and frequency remaining the same
since that time. His physician states that he is supportive of Mr.
Palomares receiving an exemption.

Mark A. Parish

Mr. Parish is a 56 year-old driver in Georgia. He has a history of
a seizure disorder and his last seizure was in 2008. He takes anti-
seizure medication with the dosage and frequency remaining the same
since 2014. His physician states that he is supportive of Mr. Parish
receiving an exemption.

Rickie M. Rineer

Mr. Rineer is a 64 year-old driver in Pennsylvania. He has a
history of a seizure disorder and his last seizure was in 1981. He
takes anti-seizure medication with the dosage and frequency remaining
the same since that time. His physician states that he is supportive of
Mr. Rineer receiving an exemption.

Timothy Wolsieffer

Mr. Wolsieffer is a 61 year-old driver in Pennsylvania. He has a
history of a seizure disorder and his last seizure was in 1998. He
takes anti-seizure medication with the dosage and frequency remaining
the same since that time. His physician states that he is supportive of
Mr. Wolsieffer receiving an exemption.

III. Request for Comments

In accordance with 49 U.S.C. 31136(e) and 31315, FMCSA requests
public comment from all interested persons on the exemption petitions
described in this notice. We will consider all comments received before
the close of business on the closing date indicated in the dates
section of the notice.

IV. Submitting Comments

You may submit your comments and material online or by fax, mail,
or hand delivery, but please use only one of these means. FMCSA
recommends that you include your name and a mailing address, an email
address, or a phone number in the body of your document so that FMCSA
can contact you if there are questions regarding your submission.
To submit your comment online, go to http://www.regulations.gov and
in the search box insert the docket number ``FMCSA-2017-0178'' and
click the search button. When the new screen appears, click on the blue
``Comment Now!'' button on the right and side of the page. On the new
page, enter information required including the specific section of this
document to which each comment applies, and provide a reason for each
suggestion or recommendation. If you submit your comments by mail or
hand delivery, submit them in an unbound format, no larger than 8\1/2\
by 11 inches, suitable for copying and electronic filing. If you submit
comments by mail and would like to know that they reached the facility,
please enclose a stamped, self-addressed postcard or envelope.
We will consider all comments and materials received during the
comment period. FMCSA may issue a final determination any time after
the close of the comment period.

V. Viewing Comments and Documents

To view comments, as well as any documents mentioned in this
preamble, go to http://www.regulations.gov and in the search box insert
the docket number FMCSA-2017-0178 and click ``Search.'' Next, click
``Open Docket Folder'' and you will find all documents and comments
related to this notice.

Issued on: June 21, 2017.
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2017-13618 Filed 6-28-17; 8:45 am]
BILLING CODE 4910-EX-P

29624 Federal Register / Vol. 82, No. 124 / Thursday, June 29, 2017 / Notices

the online instructions for sending your McDonnell Douglas Model MD–11F With the approval of the chairman,
comments electronically. airplanes. members of the public may present oral
• Mail: Send comments to Docket [FR Doc. 2017–13596 Filed 6–28–17; 8:45 am] statements at the meeting. Persons
Operations, M–30; U.S. Department of BILLING CODE 4910–13–P wishing to present statements or obtain
Transportation (DOT), 1200 New Jersey information should contact the person
Avenue SE., Room W12–140, West listed in the FOR FURTHER INFORMATION
Building Ground Floor, Washington, DC DEPARTMENT OF TRANSPORTATION CONTACT section. Members of the public
20590–0001. may present a written statement to the
Federal Aviation Administration
• Hand Delivery or Courier: Take committee at any time.
comments to Docket Operations in Ninth RTCA SC–235 Non Rechargeable Issued in Washington, DC, on June 26,
Room W12–140 of the West Building Lithium Batteries Plenary 2017.
Ground Floor at 1200 New Jersey Mohannad Dawoud,
Avenue SE., Washington, DC, between 9 AGENCY: Federal Aviation Management and Program Analyst,
a.m. and 5 p.m., Monday through Administration (FAA), Department of Partnership Contracts Branch, ANG–A17,
Friday, except Federal holidays. Transportation (DOT). NextGen, Procurement Services Division,
• Fax: Fax comments to Docket ACTION: Ninth RTCA SC–235 Non Federal Aviation Administration.
Operations at 202–493–2251. Rechargeable Lithium Batteries Plenary. [FR Doc. 2017–13606 Filed 6–28–17; 8:45 am]
Privacy: In accordance with 5 U.S.C. BILLING CODE 4910–13–P
553(c), DOT solicits comments from the SUMMARY: The FAA is issuing this notice
public to better inform its rulemaking to advise the public of a meeting of
process. DOT posts these comments, Ninth RTCA SC–235 Non Rechargeable DEPARTMENT OF TRANSPORTATION
without edit, including any personal Lithium Batteries Plenary.
information the commenter provides, to DATES: The meeting will be held July 13, Federal Motor Carrier Safety
http://www.regulations.gov, as 2017, 12:00 p.m.–1:00 p.m. Administration
described in the system of records ADDRESSES: The meeting will be held [Docket No. FMCSA–2017–0178]
notice (DOT/ALL–14 FDMS), which can virtually at: https://rtca.webex.com/
be reviewed at http://www.dot.gov/ rtca/j.php?MTID=m9ab27f37950b7 Qualification of Drivers; Exemption
privacy. c41fb2cc743ef8b5891, Join by phone, 1– Applications; Epilepsy and Seizure
Docket: Background documents or 877–668–4493, Call-in toll-free number Disorders
comments received may be read at (US/Canada), 1–650–479–3208, Call-in
http://www.regulations.gov at any time. toll number (US/Canada), Access code: AGENCY: Federal Motor Carrier Safety
Follow the online instructions for 638 570 306, Meeting Password: Administration (FMCSA), DOT.
accessing the docket or go to the Docket tP6B8u5E. ACTION: Notice of applications for
Operations in Room W12–140 of the exemption; request for comments.
FOR FURTHER INFORMATION CONTACT:
West Building Ground Floor at 1200 Karan Hofmann at khofmann@rtca.org SUMMARY: FMCSA announces receipt of
New Jersey Avenue SE., Washington, or 202–330–0680, or The RTCA applications from seven individuals for
DC, between 9 a.m. and 5 p.m., Monday Secretariat, 1150 18th Street NW., Suite an exemption from the prohibition in
through Friday, except Federal holidays. 910, Washington, DC 20036, or by the Federal Motor Carrier Safety
FOR FURTHER INFORMATION CONTACT: telephone at (202) 833–9339, fax at (202) Regulations (FMCSRs) against persons
Lynette Mitterer, ANM–113, Federal 833–9434, or Web site at http:// with a clinical diagnosis of epilepsy or
Aviation Administration, 1601 Lind www.rtca.org. any other condition that is likely to
Avenue SW., Renton, WA 98057–3356, cause a loss of consciousness or any loss
email Lynette.Mitterer@faa.gov, phone SUPPLEMENTARY INFORMATION: Pursuant
to section 10(a)(2) of the Federal of ability to control a commercial motor
(425) 227–1047; or Alphonso vehicle (CMV) to drive in interstate
Pendergrass, ARM–200, Office of Advisory Committee Act (Pub. L. 92–
463, 5 U.S.C., App.), notice is hereby commerce. If granted, the exemptions
Rulemaking, Federal Aviation would enable these individuals who
Administration, 800 Independence given for a meeting of the Ninth RTCA
SC–235 Non Rechargeable Lithium have had one or more seizures and are
Avenue SW., Washington, DC 20591, taking anti-seizure medication to
email alphonso.pendergrass@faa.gov, Batteries Plenary. The agenda will
include the following: operate CMVs in interstate commerce.
phone (202) 267–4713.
DATES: Comments must be received on
This notice is published pursuant to Thursday, July 13, 2017, 12:00 p.m.– or before July 31, 2017.
14 CFR 11.85. 2:00 p.m.
ADDRESSES: You may submit comments
Issued in Renton, Washington. 1. Welcome and Administrative bearing the Federal Docket Management
Victor Wicklund, Remarks (Including DFO & RTCA System (FDMS) Docket No. FMCSA–
Manager, Transport Standards Staff. Statement) 2017–0178 using any of the following
2. Introductions methods:
Petition for Exemption 3. Agenda Review • Federal eRulemaking Portal: Go to
Docket No.: FAA–2017–0645. 4. Meeting-Minutes Review http://www.regulations.gov. Follow the
Petitioner: Western Global Airlines. 5. Final Review and Comment (FRAC) online instructions for submitting
Section of 14 CFR Affected: Resolution Review comments.
sradovich on DSK3GMQ082PROD with NOTICES

§§ 25.785(j), 25.812(e), 25.813(b), 6. Approval of DO–227A for Submission • Mail: Docket Management Facility;
25.857(e), 25.1447(c)(1). to RTCA PMC U.S. Department of Transportation, 1200
Description of Relief Sought: Allow 7. Action Item Review New Jersey Avenue SE., West Building
for the carriage of up to two 8. Any Other Business Ground Floor, Room W12–140,
supernumeraries and allowing those 9. Adjourn Washington, DC 20590–0001.
supernumeraries in-flight access to Attendance is open to the interested • Hand Delivery: West Building
Class E cargo compartment of the public but limited to space availability. Ground Floor, Room W12–140, 1200

VerDate Sep<11>2014 18:29 Jun 28, 2017 Jkt 241001 PO 00000 Frm 00151 Fmt 4703 Sfmt 4703 E:\FR\FM\29JNN1.SGM 29JNN1

Federal Register / Vol. 82, No. 124 / Thursday, June 29, 2017 / Notices 29625

New Jersey Avenue SE., Washington, The nine individuals listed in this Drivers who have a history of
DC, between 9 a.m. and 5 p.m., e.t., notice have requested an exemption epilepsy/seizures, off anti-seizure
Monday through Friday, except Federal from the epilepsy prohibition in 49 CFR medication and seizure-free for 10 years,
Holidays. 391.41(b)(8). Accordingly, the Agency may be qualified to operate a CMV in
• Fax: 1–202–493–2251. will evaluate the qualifications of each interstate commerce. Interstate drivers
Instructions: Each submission must applicant to determine whether granting who have had a single unprovoked
include the Agency name and the the exemption will achieve the required seizure may be qualified to drive a CMV
docket number(s) for this notice. Note level of safety mandated by statute. in interstate commerce if seizure-free
that all comments received will be The physical qualification standard and off anti-seizure medication for five
posted without change to http:// for drivers regarding epilepsy found in years or more.
www.regulations.gov, including any 49 CFR 391.41(b)(8) states that a person As a result of Medical Examiners
personal information provided. Please is physically qualified to drive a CMV misinterpreting advisory criteria as
see the Privacy Act heading below for if that person: regulation, numerous drivers have been
further information. Has no established medical history or prohibited from operating a CMV in
Docket: For access to the docket to clinical diagnosis of epilepsy or any other interstate commerce based on the fact
read background documents or condition which is likely to cause the loss of that they have had one or more seizures
comments, go to http:// consciousness or any loss of ability to control and are taking anti-seizure medication,
www.regulations.gov at any time or a CMV. rather than an individual analysis of
Room W12–140 on the ground level of In addition to the regulations, FMCSA their circumstances by a qualified
the West Building, 1200 New Jersey has published advisory criteria 1 to Medical Examiner based on the physical
Avenue SE., Washington, DC, between 9 assist Medical Examiners in qualification standards and medical best
a.m. and 5 p.m., e.t., Monday through determining whether drivers with practices.
Friday, except Federal holidays. The certain medical conditions are qualified On January 15, 2013, in a Notice of
FDMS is available 24 hours each day, to operate a CMV in interstate Final Disposition entitled,
365 days each year. If you want commerce. [49 CFR part 391, ‘‘Qualification of Drivers; Exemption
acknowledgment that we received your APPENDIX A TO PART 391—MEDICAL Applications; Epilepsy and Seizure
comments, please include a self- ADVISORY CRITERIA, section H. Disorders,’’ (78 FR 3069), FMCSA
addressed, stamped envelope or Epilepsy: § 391.41(b)(8), paragraphs 3, 4, announced its decision to grant requests
postcard or print the acknowledgement and 5.] from 22 individuals for exemptions
page that appears after submitting The advisory criteria state the from the regulatory requirement that
comments online. following: interstate CMV drivers have ‘‘no
Privacy Act: In accordance with 5
If an individual has had a sudden established medical history or clinical
U.S.C. 553(c), DOT solicits comments
episode of a non-epileptic seizure or diagnosis of epilepsy or any other
from the public to better inform its
loss of consciousness of unknown cause condition which is likely to cause loss
rulemaking process. DOT posts these
that did not require anti-seizure of consciousness or any loss of ability to
comments, without edit, including any
medication, the decision whether that control a CMV.’’ Since the January 15,
personal information the commenter
person’s condition is likely to cause the 2013 notice, the Agency has published
provides, to http://www.regulations.gov
loss of consciousness or loss of ability additional notices granting requests
as described in the system records
to control a CMV should be made on an from individuals for exemptions from
notice (DOT/ALL–14 FDMS), which can
individual basis by the Medical the regulatory requirement regarding
be reviewed at http://www.dot.gov/
Examiner in consultation with the epilepsy found in 49 CFR 391.41(b)(8).
privacy.
treating physician. Prior to considering To be considered for an exemption
FOR FURTHER INFORMATION CONTACT: Ms. certification, it is suggested there be a from the epilepsy prohibition in 49 CFR
Christine A. Hydock, Chief, Medical six-month waiting period from the time 391.41(b)(8), applicants must meet the
Programs Division, (202) 366–4001, of the episode. Following the waiting criteria in the 2007 recommendations of
fmcsamedical@dot.gov, FMCSA, period, it is suggested that the the Agency’s Medical Expert Panel
Department of Transportation, 1200 individual undergo a complete (MEP) (78 FR 3069).
New Jersey Avenue SE., Room W64– neurological examination. If the results
224, Washington, DC 20590–0001. of the examination are negative and II. Qualifications of Applicants
Office hours are 8:30 a.m. to 5 p.m., e.t., anti-seizure medication is not required, Richard A. Bailey
Monday through Friday, except Federal the driver may be qualified.
holidays. If you have questions In those individual cases where a Mr. Bailey is a 67 year-old class A
regarding viewing or submitting driver had a seizure or an episode of CDL holder in Iowa. He has a history of
material to the docket, contact Docket loss of consciousness that resulted from a seizure disorder and his last seizure
Services, telephone (202) 366–9826. a known medical condition (e.g., drug was 2009. He takes anti-seizure
SUPPLEMENTARY INFORMATION: reaction, high temperature, acute medication with the dosage and
infectious disease, dehydration, or acute frequency remaining the same since that
I. Background time. His physician states that he is
metabolic disturbance), certification
Under 49 U.S.C. 31136(e) and 31315, should be deferred until the driver has supportive of Mr. Bailey receiving an
FMCSA may grant an exemption from recovered fully from that condition, has exemption.
the FMCSRs for a two-year period if it
sradovich on DSK3GMQ082PROD with NOTICES

no existing residual complications, and Roosevelt J. Chambers
finds ‘‘such exemption would likely is not taking anti-seizure medication.
achieve a level of safety that is Mr. Chambers is a 71 year-old driver
equivalent to or greater than the level 1 See http://www.ecfr.gov/cgi-bin/text-idx?SID= in Washington. He has a history of
that would be achieved absent such e47b48a9ea42dd67d999246e23d97970&mc epilepsy and his last seizure was in
=true&node=pt49.5.391&rgn=div5#ap49.5.391_
exemption.’’ The statute also allows the 171.a and https://www.gpo.gov/fdsys/pkg/CFR-
2007. He takes anti-seizure medication
Agency to renew exemptions at the end 2015-title49-vol5/pdf/CFR-2015-title49-vol5-part with the dosage and frequency
of the two-year period. 391-appA.pdf. remaining the same since 2006. His

VerDate Sep<11>2014 18:29 Jun 28, 2017 Jkt 241001 PO 00000 Frm 00152 Fmt 4703 Sfmt 4703 E:\FR\FM\29JNN1.SGM 29JNN1

Document Created: 2018-11-14 10:17:43
Document Modified: 2018-11-14 10:17:43

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Action		Notice of applications for exemption; request for comments.
Dates		Comments must be received on or before July 31, 2017.
Contact		Ms. Christine A. Hydock, Chief, Medical Programs Division, (202) 366-4001, [email protected], FMCSA, Department of Transportation, 1200 New Jersey Avenue SE., Room W64-224, Washington, DC 20590-0001. Office hours are 8:30 a.m. to 5 p.m., e.t., Monday through Friday, except Federal holidays. If you have questions regarding viewing or submitting material to the docket, contact Docket Services, telephone (202) 366-9826.
FR Citation		82 FR 29624

82 FR 29624 - Qualification of Drivers; Exemption Applications; Epilepsy and Seizure Disorders

DEPARTMENT OF TRANSPORTATIONFederal Motor Carrier Safety Administration

Federal Register Volume 82, Issue 124 (June 29, 2017)

DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety Administration